검색어 : 통합검색[Partridge Ian]
총 174건 중 174건 출력
, 6/18 페이지
-
51
- Stability of Cholesterol and Paprika Carotenoids in Egg Powders as Influenced by Dietary and Processing Treatments
- Lai, Shu-Mei; Gray, J Ian; Partridge, John A; Flegal, Cal J; ; (Journal of the science of food and agriculture, v.72, 1996, pp.171-178)
-
52
- Letter to the Editor: Aseptic Loosening of Total Hip Arthroplasty: Infection Always Should be Ruled Out
- Partridge, David G.; Rambani, Reena; Kerry, Robert M.; Stockley, Ian; Townsend, Robert; ; (Clinical orthopaedics and related research, v.469, 2011, pp.2971-2972)
-
53
- Reduced molecular expression of K<sup>+</sup>channel proteins in vascular smooth muscle from rats made hypertensive with<i>N</i><sup>ω</sup>-nitro-<small>L</small>-arginine
- Bratz, Ian N.; Dick, Gregory M.; Partridge, L. Donald; Kanagy, Nancy L.; ; (American journal of physiology, Heart and circulatory physiology, v.289, 2005, pp.H1277-H1283)
-
54
- Aquatic prey use countershading camouflage to match the visual background
- Kelley Jennifer L; Taylor Ian; Hart Nathan S; Partridge Julian C; ; (Behavioral Ecology, v.28, 2017, pp.1314-1322)
-
55
- pEl1573 Carrying <i>bla</i><sub>IMP-4</sub> , from Sydney, Australia, Is Closely Related to Other IncL/M Plasmids
- Partridge, Sally R.; Ginn, Andrew N.; Paulsen, Ian T.; Iredell, Jonathan R.; Centre for Infectious Diseases and Microbiology, Westmead Hospital, Westmead, New South Wales, Australia; Centre for Infectious Diseases and Microbiology, Westmead Hospital, Westmead, New South Wales, Australia; Department of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, New South Wales, Australia; Centre for Infectious Diseases and Microbiology, Westmead Hospital, Westmead, New South Wales, Australia; (Antimicrobial agents and chemotherapy, v.56, 2012, pp.6029-6032)
-
56
- Enrichment of specific mRNAs in cytoskeletal-bound and membrane-bound polysomes in Chinese hamster ovary cells
- HESKETH, JOHN; JODAR, DIEGO; JOHANNESSEN, ARILD; PARTRIDGE, KRIS; PRYME, IAN; TAULER, ALBERT; Intracellular Targeting Group, Rowett Research Institute, Aberdeen AB2 9SB, U.K.; Faculty of Pharmacy, University of Barcelona, Spain; Department of Biochemistry and Molecular Biology, University of Bergen, Norway; Intracellular Targeting Group, Rowett Research Institute, Aberdeen AB2 9SB, U.K.; Department of Biochemistry and Molecular Biology, University of Bergen, Norway; Faculty of Pharmacy, University of Barcelona, Spain; (Biochemical Society transactions, v.24, 1996, pp.187S-187S)
-
57
- Assessing American black bear response to human activity at Kenai Fjords National Park, Alaska
- Smith, Tom S.; Oyster, Jared; Partridge, Steven D.; Martin, Ian E.; Sisson, Aaron; ; (Ursus : an official publication of the International Association for Bear Research and Management, v.23, 2012, pp.179-191)
-
58
- British and Irish Hypertension Society response to ‘RAAS inhibitors in pregnancy, breastfeeding and women of childbearing potential: a review of national and international clinical practice guidelines’
- Faconti, Luca; Abrams, Louise; Jenner, Bernadette; Shantsila, Eduard; Partridge, Sarah; Wilkinson, Ian B.; ; (Journal of human hypertension, v.39, 2025, pp.313-314)
-
59
- Abstract PO3-18-11: A011801 (CompassHER2 RD): Postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer
- O'Sullivan, Ciara; Ballman, Karla; McCall, Linda; Zemla, Tyler; Weiss, Anna; Mitchell, Melissa; Blinder, Victoria; Tung, Nadine; Irvin, William; Lee, Myounghee; Kamaraju, Sailaja; Goetz, Matthew; Symmans, W. Fraser; Borges, Virginia; Krop, Ian; Partridge, Ann; Carey, Lisa; 1Mayo Clinic, Rochester, MN, USA, ROCHESTER, Minnesota, United States,; 2Weill Cornell Medicine, New York, New York, United States,; 3Duke University,; 4MAYO CLINIC,; 5Division of Surgical Oncology, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States,; 6UT MD Anderson Cancer Center, Houston, Texas, United States,; 7Memorial Sloan Kettering Cancer Center,; 8Beth Israel Deaconess Medical Center,; 9Bon Secours Saint Francis Medical Center Cancer Institute/Southeast Clinical Oncology Research (SCOR), Midlothian, Virginia, United States,; 10University of Maryland Medical Center,; 11Medical College of Wisconsin, Milwaukee, Wisconsin, United States,; 12Mayo Clinic, Rochester, Minnesota, United States,; 13UT MD Anderson Cancer Center,; 14University of Colorado Anschutz Medical Center,; 15Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, United States,; 16Dana-Farber Cancer Institute, Boston, Massachusetts, United States; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.84, 2024, pp.PO3-18-11-PO3-18-11)
-
60
- Initial characterization of an anti-actin monoclonal antibody (NH3)
- DRANSFIELD, IAN; MOIR, ARTHUR J. G.; SHETH, BHAV; BURTON, DENNIS R.; PARTRIDGE, LYNDA J.; Department of Biochemistry, University of Sheffield, Sheffield S10 2TN, U.K.; Department of Biochemistry, University of Sheffield, Sheffield S10 2TN, U.K.; Department of Biochemistry, University of Sheffield, Sheffield S10 2TN, U.K.; Department of Biochemistry, University of Sheffield, Sheffield S10 2TN, U.K.; Department of Biochemistry, University of Sheffield, Sheffield S10 2TN, U.K.; (Biochemical Society transactions, v.16, 1988, pp.163-164)
QUICK MENU
